# Eli Lilly (LLY) return on equity (ROE): 77.8% in 2025

URL: https://funkfolio.com/stock/LLY/roe

> Eli Lilly (LLY) return on equity (ROE) was 77.8% in fiscal 2025, up 3.6 points from fiscal 2024. Its median over 17 fiscal years is 32.9%.

---

## Eli Lilly (LLY) return on equity (ROE)

**Return on equity · fiscal 2025:** 77.8% year ended Dec 31, 2025

Eli Lilly (LLY) earned a return on equity of 77.8% in fiscal 2025 (the year ended December 31, 2025). That is 3.6 percentage points higher than the 74.2% of fiscal 2024. Figures as of 17 Nov 2026, 23:22 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Return on equity, fiscal 2025:** 77.8%
- **Change on fiscal 2024:** +3.6 pts
- **Highest on record:** 319.1% fiscal 2019
- **Lowest on record:** -30.8% fiscal 2008
- **Fiscal years on record:** 18 2008–2025

Figures as of 17 Nov 2026, 23:22 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Eli Lilly return on equity (ROE), in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 319.1% in fiscal 2019 and the lowest -30.8% in fiscal 2008. The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is 32.9%.

### Return on equity by fiscal year

### Eli Lilly return on equity (ROE), year by year

Eli Lilly (LLY) return on equity (ROE) by fiscal year

| Fiscal year | Return on equity | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | 77.8% | 3.6 pts up | Dec 31, 2025 |
| 2024 | 74.2% | 25.6 pts up | Dec 31, 2024 |
| 2023 | 48.6% | 10.0 pts down | Dec 31, 2023 |
| 2022 | 58.6% | 3.5 pts down | Dec 31, 2022 |
| 2021 | 62.2% | 47.6 pts down | Dec 31, 2021 |
| 2020 | 109.8% | 209.3 pts down | Dec 31, 2020 |
| 2019 | 319.1% | 286.2 pts up | Dec 31, 2019 |
| 2018 | 32.9% | 34.6 pts up | Dec 31, 2018 |
| 2017 | -1.8% | 21.3 pts down | Dec 31, 2017 |
| 2016 | 19.5% | 3.0 pts up | Dec 31, 2016 |
| 2015 | 16.5% | 1.0 pts up | Dec 31, 2015 |
| 2014 | 15.5% | 11.0 pts down | Dec 31, 2014 |
| 2013 | 26.6% | 1.1 pts down | Dec 31, 2013 |
| 2012 | 27.7% | 4.4 pts down | Dec 31, 2012 |
| 2011 | 32.1% | 8.7 pts down | Dec 31, 2011 |
| 2010 | 40.8% | 4.6 pts down | Dec 31, 2010 |
| 2009 | 45.4% | 76.2 pts up | Dec 31, 2009 |
| 2008 | -30.8% | — | Dec 31, 2008 |

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

### How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

### Return on equity at health care companies of similar size

Return on equity of Eli Lilly and comparable companies

| Company | Return on equity | Fiscal year |
| --- | --- | --- |
| Eli Lilly LLY | 77.8% | 2025 |
| [Johnson & Johnson JNJ](https://funkfolio.com/stock/JNJ/roe) | 32.9% | 2025 |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/roe) | 128.7% | 2024 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/roe) | 34.7% | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/roe) | 12.8% | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/roe) | 30.3% | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Eli Lilly, figure by figure

- [Eli Lilly market cap](https://funkfolio.com/stock/LLY/market-cap)
- [Eli Lilly revenue](https://funkfolio.com/stock/LLY/revenue)
- [Eli Lilly earnings](https://funkfolio.com/stock/LLY/earnings)
- [Eli Lilly earnings per share (EPS)](https://funkfolio.com/stock/LLY/eps)
- [Eli Lilly P/E ratio](https://funkfolio.com/stock/LLY/pe-ratio)
- [Eli Lilly P/S ratio](https://funkfolio.com/stock/LLY/ps-ratio)
- [Eli Lilly P/B ratio](https://funkfolio.com/stock/LLY/pb-ratio)
- [Eli Lilly free cash flow](https://funkfolio.com/stock/LLY/free-cash-flow)
- [Eli Lilly operating margin](https://funkfolio.com/stock/LLY/operating-margin)
- [Eli Lilly dividend](https://funkfolio.com/stock/LLY/dividend)
- [Eli Lilly shares outstanding](https://funkfolio.com/stock/LLY/shares-outstanding)
- [Eli Lilly total debt](https://funkfolio.com/stock/LLY/total-debt)
- [Eli Lilly cash on hand](https://funkfolio.com/stock/LLY/cash)
- [Eli Lilly total assets](https://funkfolio.com/stock/LLY/total-assets)
- [Eli Lilly return on invested capital (ROIC)](https://funkfolio.com/stock/LLY/roic)

[Eli Lilly (LLY) overview: price, valuation and scorecard](https://funkfolio.com/stock/LLY) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Eli Lilly return on equity (ROE): questions and answers

**What is Eli Lilly's return on equity?**

Eli Lilly (LLY) earned a return on equity of 77.8% in fiscal 2025 (the year ended December 31, 2025). That is 3.6 percentage points higher than the 74.2% of fiscal 2024.

**Is Eli Lilly's return on equity high or low compared with its own history?**

The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is 32.9%.

**What are the highest and lowest return on equity figures on record for Eli Lilly?**

Across the 18 fiscal years on record (2008–2025), the highest was 319.1% in fiscal 2019 and the lowest -30.8% in fiscal 2008.

**How is Eli Lilly's return on equity calculated?**

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

### Learn: return on equity (ROE)

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Return on invested capital (ROIC) vs ROE and ROA](https://funkfolio.com/learn/stocks/return-on-invested-capital)

  Return on invested capital (ROIC) is after-tax operating profit divided by the money tied up in the business: debt plus equity, less cash. A company earning $15 million after tax on $100 million of invested capital has a 15% ROIC. Unlike return on equity, it does not rise just because a company borrows more.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Eli Lilly (LLY) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/LLY/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.
